Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | AHR | P35869 | 4/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | MAT2A | P31153 | 7/20 | 0.40 |
| ▸ | EDNRA | P25101 | 1/20 | 0.39 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.38 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23314294 | 0.95 | AHR (0.52) | L3MBTL1KDM4EATMAHRADORA3 | |
| SCHEMBL23314468 | 0.95 | KDM4E (0.46) | L3MBTL1KDM4EATMAHRTNKS | |
| SCHEMBL23314486 | 0.94 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMAHRADORA3 | |
| SCHEMBL23314461 | 0.93 | KDM4E (0.44) | L3MBTL1KDM4EATMAHRADORA3 | |
| SCHEMBL11965559 | 0.92 | KDM4E (0.55) | L3MBTL1KDM4EATMMAPK8MEN1 | |
| SCHEMBL23314450 | 0.91 | AHR (0.44) | L3MBTL1KDM4EATMAHRTNKS | |
| SCHEMBL20737606 | 0.90 | AHR (0.49) | L3MBTL1KDM4EATMAHRTNKS | |
| SCHEMBL16904418 | 0.89 | KDM4E (0.51) | L3MBTL1KDM4EATMAHRMEN1 | |
| SCHEMBL23314359 | 0.88 | AHR (0.49) | L3MBTL1KDM4EATMAHRADORA3 | |
| SCHEMBL24789226 | 0.88 | AHR (0.44) | L3MBTL1KDM4EATMAHRADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210242408-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2021-08-05 | — | — | US | disclosed |
| US-10998502-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2021-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10998502-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | OR51E2, ETV6, OR10J3 | L3MBTL1 710/4885KDM4E 575/4885ATM 3385/4885 |
| US-20210242408-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | OR10J3, OR51E2, ORAI2 | L3MBTL1 819/4885KDM4E 751/4885ATM 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.